These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 10161585)

  • 1. Formularies in integrated health systems: Sharp HealthCare.
    Rizos AL; Levy E; Furnier J; Crowley K
    J Healthc Resour Manag; 1996 Sep; 14(7):14-9. PubMed ID: 10161585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formularies in integrated health systems: Sharp HealthCare.
    Rizos AL; Levy E; Furnier J; Crowley K
    Am J Health Syst Pharm; 1996 Feb; 53(3):274-8. PubMed ID: 8808022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy formularies in integrated health systems.
    Osborne JA
    J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The three dimensions of managed care pharmacy practice.
    Gouveia WA; Shane R
    Am J Manag Care; 1997 Feb; 3(2):231-9. PubMed ID: 10169257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulary: what it is and how it works.
    Smith G
    J Healthc Resour Manag; 1996 Sep; 14(7):11-3. PubMed ID: 10161584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managed care guidelines for the economic evaluation of pharmaceuticals.
    Langley PC; Martin RE
    Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating clinical outcomes and economic consequences into drug formulary decisions: a practical approach.
    Mather DB; Sullivan SD; Augenstein D; Fullerton DS; Atherly D
    Am J Manag Care; 1999 Mar; 5(3):277-85. PubMed ID: 10351024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the clinic: redefining hospital ambulatory care.
    Rogut L
    Pap Ser United Hosp Fund N Y; 1997 Jul; ():1-62. PubMed ID: 10351749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of formulary system policies and procedures.
    Rascati KL
    Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
    Fry RN; Avey SG; Sullivan SD
    Value Health; 2003; 6(5):505-21. PubMed ID: 14627057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managed care organizations: an introduction--Part I of II.
    Vogenberg FR
    Hosp Pharm; 1995 Jan; 30(1):40, 43-4. PubMed ID: 10139730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug formulary commentary: an integrated health systems approach.
    Boyer ST
    Pharm Pract Manag Q; 1995 Oct; 15(3):83-5. PubMed ID: 10151716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.